ResMed Inc/ US7611521078 /
| 2024-06-07 10:10:00 PM | Chg. -0.65 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 210.91USD | -0.31% | 411,980 Turnover: 51.31 mill. |
208.00Bid Size: 100 | 221.00Ask Size: 100 | 30.98 bill.USD | 0.83% | 34.46 |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 394.2410 | 386.5500 | 387.4600 | 417.3350 | 463.4900 | ||||||
| Intangible Assets | 261.8000 | 215.1840 | 521.9500 | 448.1680 | 392.5820 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 1,824.4840 | 1,998.2060 | 2,962.3160 | 3,063.9170 | 3,153.3680 | ||||||
| Inventories | 268.3190 | 268.7010 | 349.6410 | 416.9150 | 457.0330 | ||||||
| Accounts Receivable | 450.5300 | 483.6810 | 528.4840 | 474.6430 | 614.2920 | ||||||
| Cash and Cash Equivalents | 821.9350 | 188.7010 | 147.1280 | 463.1560 | 295.2780 | ||||||
| Current Assets | 1,644.0030 | 1,065.7170 | 1,145.3660 | 1,523.4590 | 1,574.7570 | ||||||
| Total Assets | 3,468.4870 | 3,063.9230 | 4,107.6820 | 4,587.3760 | 4,728.1250 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 92.7630 | 92.7230 | 115.7250 | 135.7860 | 138.0080 | ||||||
| Long-term debt | 1,078.6110 | 269.9880 | 1,258.8610 | 1,164.1330 | 643.3510 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 1,508.2210 | 1,004.9430 | 2,035.4890 | 2,090.3490 | 1,842.4460 | ||||||
| Share Capital | .5690 | .5710 | .5750 | .5800 | .5830 | ||||||
| Total Equity | 1,960.2660 | 2,058.9800 | 2,072.1930 | 2,497.0270 | 2,885.6790 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 3,468.4870 | 3,063.9230 | 4,107.6820 | 4,587.3760 | 4,728.1250 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,066.7370 | 2,340.1960 | 2,606.5720 | 2,957.0130 | 3,196.8250 | ||||||
| Depreciation (total) | 112.1570 | 119.9600 | 150.7950 | 154.8500 | 156.7580 | ||||||
| Operating Result | 425.7980 | 541.8310 | 579.2630 | 809.6590 | 903.6780 | ||||||
| Interest Income | -11.1510 | -11.9770 | -33.8570 | -39.3560 | -23.6270 | ||||||
| Income Before Taxes | 418.7430 | 521.3120 | 518.8470 | 733.0880 | 883.6620 | ||||||
| Income Taxes | 76.4590 | 205.7240 | 114.2550 | 111.4140 | 409.1570 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 342.2840 | 315.5880 | 404.5920 | 621.6740 | 474.5050 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 414.0530 | 505.0260 | 459.0510 | 802.2550 | 736.7180 | ||||||
| Cash Flow from Investing Activities | -81.8900 | -101.8240 | -1,075.7060 | -179.8610 | -158.4620 | ||||||
| Cash Flow from Financing | -262.8670 | -1,026.6940 | 580.6430 | -317.2860 | -764.6320 | ||||||
| Decrease / Increase in Cash | 90.5010 | -633.2340 | -41.5730 | 316.0280 | -167.8780 | ||||||
| Employees | 6,080 | 5,940 | 7,240 | 7,700 | - | ||||||
